Recombinant Chicken Epidermal growth factor receptor (EGFR), partial

What is the structure and function of chicken EGFR?

Chicken Epidermal Growth Factor Receptor (EGFR) is a receptor tyrosine kinase (RTK) that plays crucial roles in cellular signaling pathways. The receptor contains an extracellular ligand-binding domain, a transmembrane domain, and an intracellular tyrosine kinase domain. When activated by ligands such as EGF, the receptor undergoes dimerization and autophosphorylation, creating binding sites for various signaling molecules containing SH2 domains.

The phosphorylated form of EGFR serves as a docking site for proteins containing SH2 domains, including cellular homologs of viral oncoproteins such as v-Crk. Studies have demonstrated that both full-length Crk and isolated SH2 domains of proteins like GAP or Abl can bind to phosphorylated chicken EGFR with high affinity . This binding protects EGFR from dephosphorylation by cellular phosphatases, thereby potentially prolonging its signaling capacity .

How does chicken EGFR differ from mammalian EGFR?

Chicken EGFR shares significant homology with mammalian EGFR but exhibits some distinct characteristics. While the core functional domains are conserved, chicken EGFR has unique binding affinities and interaction patterns with SH2 domain-containing proteins. In competitive binding assays, both full-length Crk and GAPSH2[N] bind to phosphorylated chicken EGFR with high affinity and can quantitatively compete with each other .

In terms of developmental expression, chicken EGFR has been detected in various embryonic tissues including kidney and heart cells at early stages of development . The presence of EGFR in chicken embryos has made it a valuable model for studying receptor tyrosine kinase functions in development.

What is the physiological role of EGFR in chicken development?

EGFR plays significant roles in chicken embryonic development, being detected in various tissues including kidney and heart cells during early developmental stages . Despite its presence, studies have shown that EGF supplementation (up to 200 ng/ml) does not significantly affect whole-body protein synthesis in chicken embryos cultured in vitro .

What are the optimal methods for expressing recombinant chicken EGFR?

For producing recombinant chicken EGFR, bacterial expression systems using glutathione S-transferase (GST) fusion proteins have been successfully employed. The use of GST-fusion proteins allows for efficient purification and subsequent functional studies . Below is a methodological approach:

• Cloning: Insert the coding sequence for chicken EGFR (partial or full-length) into appropriate bacterial expression vectors containing GST tags.

• Expression conditions: Transform the construct into E. coli strains optimized for protein expression, typically grown at reduced temperatures (16-25°C) after induction to enhance proper folding.

• Purification: Use glutathione-agarose affinity chromatography to purify the GST-EGFR fusion protein.

• Functional validation: Verify the protein's functionality through binding assays with known interactors or by assessing tyrosine kinase activity.

For researchers requiring properly glycosylated EGFR with native conformation, mammalian expression systems using CHO or HEK293 cells may be more appropriate, though these systems were not specifically described in the search results.

What assays can be used to study binding interactions with recombinant chicken EGFR?

Several robust assays have been developed to study binding interactions with chicken EGFR:

• In vitro microtiter assay: This allows for quantitative assessment of binding between bacterially expressed GST-fusion proteins (such as v-Crk and c-Crk) and phosphorylated EGFR . The assay can be used to determine relative binding affinities and to conduct competitive binding studies.

• Competitive enzyme-linked immunosorbent assay (ELISA): This methodology enables researchers to compare the abilities of various SH2 domain-containing proteins to compete for binding to phosphorylated EGFR . The table below summarizes relative binding affinities of different SH2-containing proteins to chicken EGFR:

• Nitrocellulose filter binding assay: This technique has been used to demonstrate high-affinity binding of Crk to denatured p130, a major phosphotyrosine-containing protein in CT10-transformed cells . This assay can reveal binding specificities that may not be apparent in solution-based assays.

How can phosphorylation status of chicken EGFR be monitored?

Monitoring the phosphorylation status of chicken EGFR is crucial for studying its activation and signaling properties. Several approaches can be employed:

When monitoring EGFR phosphorylation in the context of overexpression studies, it's important to control for basal activation levels, as neither EGFR knock-down nor overexpression alone typically induces EGFR or ERK2 phosphorylation in the absence of ligand stimulation .

How does chicken EGFR contribute to viral uptake mechanisms?

Chicken EGFR has been implicated in facilitating viral entry, particularly for influenza A virus (IAV). Research indicates that IAV attachment results in rearrangement of signaling platforms in the plasma membrane, leading to activation of receptor tyrosine kinases including EGFR . The mechanism involves several key steps:

• Membrane reorganization: Virus attachment triggers redistribution of EGFR into lipid raft domains, as evidenced by co-patching experiments showing more than 70% overlap between EGFR and the lipid raft marker GM1 .

• Enhanced internalization: Increased EGFR abundance significantly enhances IAV uptake, as demonstrated by higher levels of virion-associated M1 protein in cells overexpressing EGFR . This accelerated virus internalization correlates with increased virus yields.

• Temporal specificity: EGFR inhibition through blocking antibodies is effective at reducing progeny virus titers only when applied during early stages of infection, suggesting a specific role in viral entry rather than later stages of viral replication .

The table below summarizes experimental approaches to modulate EGFR activity and their effects on IAV internalization:

These findings suggest that chicken EGFR serves as a co-factor for efficient IAV entry, providing a potential target for antiviral strategies .

How can contradicting data regarding EGFR's role in protein synthesis be reconciled?

The research literature presents some apparently contradictory findings regarding EGFR's role in protein synthesis, particularly in chicken embryos. While EGFR has been implicated in stimulating protein synthesis in cultured epidermal cells, studies using whole chicken embryos found that EGF supplementation (up to 200 ng/ml) did not significantly affect whole-body protein synthesis rates .

Several hypotheses may reconcile these contradictions:

• Tissue specificity: EGFR may stimulate protein synthesis only in specific cell types (e.g., epidermal cells) rather than having a global effect on whole-body protein synthesis . This tissue-specific response might be diluted when measuring whole-body effects.

• Developmental timing: The effect of EGFR activation might be dependent on developmental stage. EGF binding to chicken tissues during embryonic development reaches a peak at days 10-12 , suggesting that sensitivity to EGF stimulation varies temporally.

• Counteracting factors: Chicken embryo extract (CEE) contains not only growth-promoting factors but also growth-suppressing factors that may counteract stimulatory effects . The same may apply to endogenous factors in whole embryos that modulate EGFR signaling.

• Methodological differences: Studies showing protein synthesis stimulation often use isolated cells or tissues, while negative findings came from whole-embryo studies. The different experimental systems (isolated cells vs. whole organisms) may contribute to the discrepancies.

To resolve these contradictions, researchers should consider experimental designs that:

• Compare protein synthesis rates in isolated tissues versus whole embryos

• Examine the effects at different developmental stages

• Identify potential counteracting factors present in whole embryos

• Investigate downstream signaling pathway differences between responsive and non-responsive tissues

What are the implications of EGFR-SH2 domain interactions for cancer research?

The interactions between phosphorylated chicken EGFR and SH2 domain-containing proteins have significant implications for cancer research, particularly in understanding oncogenic transformation mechanisms. Studies have shown that both full-length Crk and isolated SH2 domains can protect phosphorylated EGFR against dephosphorylation by cellular phosphatases .

This protection mechanism may contribute to prolonged EGFR signaling in cancer cells, as sustained tyrosine phosphorylation would maintain downstream signaling pathways that promote cell proliferation and survival. The v-Crk oncoprotein, which contains SH2 and SH3 domains, can induce transformation of chicken embryo fibroblasts by influencing cellular proteins involved in growth regulation .

Specific research implications include:

• Therapeutic targeting: Understanding the specific interactions between EGFR and various SH2 domain-containing proteins could lead to the development of targeted therapies that disrupt these interactions in cancer cells.

• Biomarker development: The binding specificity of Crk to phosphorylated proteins like p130 suggests potential biomarkers for monitoring oncogenic transformation or response to therapy.

• Comparative oncology: Chicken EGFR studies provide valuable insights for comparative oncology, as the mechanisms of EGFR signaling in avian systems share similarities with, yet distinct differences from, mammalian systems.

• Resistance mechanisms: The protection against dephosphorylation conferred by SH2 domain binding may contribute to resistance against tyrosine kinase inhibitors in cancer treatment, suggesting combination strategies that target both kinase activity and protein-protein interactions.

What are common challenges in producing functional recombinant chicken EGFR?

Researchers working with recombinant chicken EGFR face several technical challenges:

• Protein folding and stability: Ensuring proper folding of the recombinant protein, particularly when expressing the full-length receptor with multiple domains. Bacterial expression systems may yield improperly folded proteins that lack native functionality.

• Post-translational modifications: Chicken EGFR undergoes extensive glycosylation and phosphorylation in vivo, which are critical for its function. Bacterial expression systems lack the machinery for these modifications, potentially affecting the protein's properties.

• Solubility issues: The transmembrane domain of EGFR can cause solubility problems during expression and purification. Expressing only the extracellular or intracellular domains separately may improve solubility.

• Autophosphorylation control: When expressing the kinase domain, spontaneous autophosphorylation can occur, making it difficult to obtain the receptor in a specific phosphorylation state for binding studies.

To address these challenges, researchers should consider:

• Using eukaryotic expression systems for studies requiring fully glycosylated EGFR

• Employing fusion tags (such as GST) to improve solubility and enable affinity purification

• Including phosphatase inhibitors during purification to preserve phosphorylation states

• Considering expression of individual domains for specific studies rather than the full-length receptor

How can binding specificity between chicken EGFR and SH2 domains be accurately assessed?

Determining binding specificity between chicken EGFR and various SH2 domain-containing proteins requires careful experimental design and controls. Based on the literature, several approaches can be employed:

• Competitive binding assays: These assays compare the abilities of different SH2 domain-containing proteins to inhibit the binding of a reference protein (e.g., Crk) to phosphorylated EGFR . The competitive ELISA methodology allows for quantitative comparison of relative binding affinities.

• Mutational analysis: Introducing specific mutations in the phosphotyrosine binding pocket of SH2 domains or in the phosphotyrosine residues of EGFR can help identify critical residues for binding specificity.

• Pull-down assays with varying stringency: Performing pull-down assays under different salt concentrations or detergent conditions can discriminate between high-affinity specific interactions and lower-affinity non-specific binding.

• Surface plasmon resonance (SPR): This technique provides real-time measurement of binding kinetics and can be used to determine association and dissociation rate constants, which together define binding affinity.

When interpreting binding data, researchers should consider:

• The phosphorylation state of EGFR, as different phosphotyrosine residues may preferentially bind different SH2 domains

• The potential for cooperative binding, where the binding of one SH2 domain may influence the binding of others

• The effects of fusion tags or expression systems on binding properties

• The differences between binding to denatured versus native conformation of the receptor

What factors affect the reliability of chicken EGFR activation studies?

Several factors can impact the reliability of studies examining chicken EGFR activation:

To ensure reliable activation studies, researchers should:

• Include appropriate positive and negative controls

• Verify EGFR expression levels and basal phosphorylation status

• Perform time-course experiments to capture activation dynamics

• Use multiple complementary methods to confirm activation status

• Consider the context of receptor activation (e.g., lipid raft localization)

What are emerging approaches for studying chicken EGFR in cellular signaling networks?

Several cutting-edge approaches are being developed to study chicken EGFR within the context of broader signaling networks:

• Proximity labeling techniques: Methods such as BioID or APEX can be used to identify proteins in close proximity to EGFR under various conditions, providing insights into dynamic signaling complexes.

• Live-cell imaging: Fluorescently tagged EGFR combined with advanced microscopy techniques allows for real-time visualization of receptor clustering, internalization, and co-localization with other cellular components.

• Systems biology approaches: Integration of proteomic, phosphoproteomic, and transcriptomic data to model EGFR signaling networks in chicken cells can reveal emergent properties not apparent from studying individual components.

• CRISPR-Cas9 genome editing: Creating specific mutations or regulatory element modifications in the endogenous chicken EGFR gene can provide insights into structure-function relationships under physiological expression levels.

• Multi-RTK analysis: Studying EGFR in conjunction with other RTKs such as c-Met can reveal synergistic or compensatory mechanisms, as suggested by studies showing that the extent of reduction in virus titers depends on the number of RTKs simultaneously affected .

These approaches offer promising avenues for deeper understanding of chicken EGFR biology beyond traditional biochemical and cell biological methods.

How might chicken EGFR research inform therapeutic approaches for viral infections?

Research on chicken EGFR's role in viral entry mechanisms, particularly for influenza A virus (IAV), has significant implications for developing novel therapeutic approaches:

• RTK inhibitors as antiviral agents: The finding that tyrosine kinase inhibitors can reduce IAV uptake by approximately 70-75% suggests that targeting RTKs including EGFR could be a strategy for developing anti-influenza therapeutics.

• Combinatorial approaches: Studies indicate that simultaneously targeting multiple RTKs (e.g., EGFR and c-Met) results in greater reduction of virus titers than targeting individual receptors . This suggests that combinatorial approaches may be more effective than single-target strategies.

• Temporal considerations for intervention: EGFR inhibition is effective at reducing virus titers only when applied during early stages of infection , highlighting the importance of timing for antiviral interventions targeting host factors.

• Lipid raft-targeted strategies: The finding that IAV attachment leads to rearrangement of signaling platforms in the plasma membrane and co-localization of EGFR with lipid rafts suggests that disrupting these membrane microdomains could impair viral entry.

• Cross-species implications: Understanding how chicken EGFR facilitates avian influenza virus entry could inform research on zoonotic transmission and species barriers, potentially leading to strategies for preventing pandemic outbreaks.

These research directions have particular relevance given the ongoing concerns about avian influenza and its potential for causing human pandemics.

What unanswered questions remain regarding the developmental roles of chicken EGFR?

Despite significant advances in understanding chicken EGFR, several important questions about its developmental roles remain unanswered:

• Tissue-specific functions: While EGFR has been detected in various embryonic tissues including kidney and heart , the specific functions in each tissue type are not fully characterized. Why does EGF stimulate protein synthesis in isolated epidermal cells but not in whole embryos?

• Temporal regulation: EGF binding to chicken tissues during embryonic development reaches a peak at days 10-12 , but the mechanisms regulating this temporal pattern and its developmental significance remain unclear.

• Ligand specificity: Besides EGF itself, the roles of other potential EGFR ligands (such as TGF-α, amphiregulin, etc.) in chicken embryonic development have not been thoroughly investigated.

• Receptor trafficking dynamics: How EGFR internalization, recycling, and degradation are regulated during different stages of chicken development remains to be elucidated.

• Cross-talk with other signaling pathways: The interaction between EGFR signaling and other developmental pathways (such as Wnt, Notch, or BMP signaling) in the context of chicken embryogenesis requires further investigation.

• Compensation mechanisms: The observation that EGF supplementation does not affect whole-body protein synthesis despite the presence of functional EGFR suggests compensatory mechanisms that warrant exploration.

Addressing these questions will require integrative approaches combining genetics, biochemistry, cell biology, and developmental biology to fully understand the complex roles of EGFR in chicken development.